http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1698450

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 439
issn 1464-4096
1464-410X
issueIdentifier 4
pageRange 436-439
publicationName BJU International
startingPage 436
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2bed3b45a6ec678a620a1401f8d3cbd4
bibliographicCitation Ryan CJ, Harzstark AH, Rosenberg J, Lin A, Claros C, Goldfine ID, Kerner JF, Small EJ, Youngren JF. A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer. BJU Int. 2008 Feb;101(4):436–9. doi: 10.1111/j.1464-410x.2007.07330.x. PMID: 18234062.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_396ad075130c1f5e3b6133c86c88fa6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a35228e221210fcbc0a12ac9c0e17ba9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b30d3719d67d355fed47ab855191a68d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc953ef9de29867c9f2889d036e94481
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f93a646e1fb087295d607fe10510e919
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22c77a02cba4a6be16bcbebe71c838f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a5b2a7df24eb6d21c6d81f818acdd62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_716d1d53d34de44595743a82321e95e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba925ca087d70756974cf3d9dc33f5d9
date 2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/j.1464-410x.2007.07330.x
https://pubmed.ncbi.nlm.nih.gov/18234062
isPartOf https://portal.issn.org/resource/ISSN/1464-410X
https://portal.issn.org/resource/ISSN/1464-4096
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21363
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A pilot dose‐escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0026587
http://id.nlm.nih.gov/mesh/M0026444
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0014961
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D017430Q000187
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D009364Q000188
http://id.nlm.nih.gov/mesh/D009637Q000627
http://id.nlm.nih.gov/mesh/D011471Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D010865
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D017526Q000187
http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f02b83a26fc01f93e52937e4314d7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3da33ba6cc57d9bd47a91ecc7cb7ba07
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.77
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4534
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128043106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129506098

Total number of triples: 67.